Previous studies found that the expression of VEGF, FGFR1–4, and their receptors markedly affected tumor aggressiveness and prognosis; however, little research on how this affects HNSCC has been published (27, 28). The gene discussed is FGFR1; the disease is head and neck squamous cell carcinoma.